Although the US and Canada typically top lists for clinical trials destinations, Europe still remains one of the most important regions. When it comes to early trials, the UK still leads Europe.
During the early stages of research, conceptualization, and then incorporation, biotech founders are under intense pressure to form a high-profile Board of Directors capable of attracting attention and successfully leading fundraising.
As we continue to navigate COVID-19, many of the biggest names in pharma and biotech are experiencing staffing shortages and hiring challenges brought on by the global pandemic.
A number of issues around employee equity can be especially difficult to handle for first-time founders and their Boards.
- « Previous
- 1
- …
- 4
- 5
- 6